Back to Search
Start Over
Calcium/calmodulin-dependent nitric oxide synthase activity in the CNS of Aplysia californica: biochemical characterization and link to cGMP pathways.
- Source :
-
Journal of inorganic biochemistry [J Inorg Biochem] 2005 Apr; Vol. 99 (4), pp. 922-8. - Publication Year :
- 2005
-
Abstract
- We characterized enzymatic activity of nitric oxide synthase (NOS) in the central nervous system of Aplysia californica, a popular experimental model in cellular and system neuroscience, and provided biochemical evidence for NO-cGMP signaling in molluscs. Aplysia NOS (ApNOS) activity, determined as citrulline formation, revealed its calcium-/calmodulin-(Ca/CaM) and NADPH dependence and it was inhibited by 50% with 5mM of W7 hydrochloride (a potent Ca/CaM-dependent phosphodiesterase inhibitor). A representative set of inhibitors for mammalian NOS isoforms also suppressed NOS activity in Aplysia. Specifically, the ApNOS was inhibited by 65-92% with 500 microM of L-NAME (a competitive NOS inhibitor) whereas d-NAME at the same concentration had no effect. S-Ethylisothiourea hydrobromide (5mM), a selective inhibitor of all NOS isoforms, suppressed ApNOS by 85%, l-N6-(1-iminoethyl)lysine dihydrochloride (L-NIL, 5mM), an iNOS inhibitor, by 78% and L-thiocitrulline (5mM) (an inhibitor of nNOS and iNOS) by greater than 95%. Polyclonal antibodies raised against rat nNOS hybridized with a putative purified ApNOS (160 kDa protein) from partially purified central nervous system homogenates in Western blot studies. Consistent with other studies, the activity of soluble guanylyl cyclase was stimulated as a result of NO interaction with its heme prosthetic group. The basal levels of cGMP were estimated by radioimmunoassay to be 44.47 fmol/microg of protein. Incubation of Aplysia CNS with the NO donors DEA/NONOate (diethylammonium (Z)-1-(N,N-diethylamino) diazen-1-ium-1,2-diolate - 1mM) or S-nitroso-N-acetylpenicillamine (1mM) and simultaneous phosphodiesterase inhibition with 3-isobutyl-1-methylxanthine (1mM) prior to the assay showed a 26-80 fold increase in basal cGMP levels. Addition of ODQ (1H-[1,2,4]oxadiazolo[4,3-a] quinoxaline-1-one - 1mM), a selective inhibitor of soluble guanylyl cyclase, completely abolished this effect. This confirms that NO may indeed function as a messenger in the molluscan CNS, and that cGMP acts as one of its effectors.
- Subjects :
- Animals
Aplysia enzymology
Aplysia metabolism
Citrulline metabolism
Cyclic GMP metabolism
Dose-Response Relationship, Drug
Enzyme Inhibitors pharmacology
Guanylate Cyclase antagonists & inhibitors
Guanylate Cyclase metabolism
Molecular Weight
NADP metabolism
Nitric Oxide Donors metabolism
Nitric Oxide Synthase antagonists & inhibitors
Nitric Oxide Synthase isolation & purification
Phosphodiesterase Inhibitors pharmacology
Protein Isoforms
Rats
Aplysia drug effects
Calcium pharmacology
Calmodulin pharmacology
Central Nervous System enzymology
Nitric Oxide Synthase metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0162-0134
- Volume :
- 99
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of inorganic biochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 15811509
- Full Text :
- https://doi.org/10.1016/j.jinorgbio.2005.01.012